118 related articles for article (PubMed ID: 6682029)
1. Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
Fedor JM; Stack RS; Pryor DB; Phillips HR
Chest; 1983 Apr; 83(4):704-6. PubMed ID: 6682029
[TBL] [Abstract][Full Text] [Related]
2. Use of calcium channel blockers in hypertrophic cardiomyopathy.
Lorell BH
Am J Med; 1985 Feb; 78(2B):43-54. PubMed ID: 4038850
[TBL] [Abstract][Full Text] [Related]
3. Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.
Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF
Circulation; 1982 Mar; 65(3):499-507. PubMed ID: 7198942
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation?
Paulus WJ; Lorell BH; Craig WE; Wynne J; Murgo JP; Grossman W
J Am Coll Cardiol; 1983 Nov; 2(5):879-86. PubMed ID: 6685150
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.
Landmark K; Sire S; Thaulow E; Amlie JP; Nitter-Hauge S
Br Heart J; 1982 Jul; 48(1):19-26. PubMed ID: 7200796
[TBL] [Abstract][Full Text] [Related]
6. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
Rosing DR; Idänpään-Heikkilä U; Maron BJ; Bonow RO; Epstein SE
Am J Cardiol; 1985 Jan; 55(3):185B-195B. PubMed ID: 3881913
[TBL] [Abstract][Full Text] [Related]
7. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
Senn M; Hess OM; Krayenbühl HP
Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of atrial fibrillation and syncope induced by calcium-channel blockers in hypertrophic cardiomyopathy.
Doiuchi J; Hamada M; Ochi T; Ito T; Kokubu T
Clin Cardiol; 1985 Mar; 8(3):176-9. PubMed ID: 4038927
[TBL] [Abstract][Full Text] [Related]
9. Adverse effect of nifedipine on left ventricular obstruction detected by pulsed Doppler echocardiography.
Matsuda M; Sekiguchi T; Sugishita Y; Ito I
Jpn Heart J; 1984 Nov; 25(6):1081-4. PubMed ID: 6543375
[TBL] [Abstract][Full Text] [Related]
10. Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.
Betocchi S; Cannon RO; Watson RM; Bonow RO; Ostrow HG; Epstein SE; Rosing DR
Circulation; 1985 Nov; 72(5):1001-7. PubMed ID: 4042288
[TBL] [Abstract][Full Text] [Related]
11. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.
Rosing DR; Kent KM; Borer JS; Seides SF; Maron BJ; Epstein SE
Circulation; 1979 Dec; 60(6):1201-7. PubMed ID: 574066
[TBL] [Abstract][Full Text] [Related]
12. [Nifedipine in hypertrophic obstructive cardiomyopathy].
Schanzenbächer P; Schick KD; Kochsiek K
Dtsch Med Wochenschr; 1982 Dec; 107(48):1842-6. PubMed ID: 6890438
[TBL] [Abstract][Full Text] [Related]
13. Effects of nifedipine on left ventricular diastolic function in patients with asymptomatic or minimally symptomatic hypertrophic cardiomyopathy.
Yamakado T; Okano H; Higashiyama S; Hamada M; Nakano T; Takezawa H
Circulation; 1990 Feb; 81(2):593-601. PubMed ID: 2297865
[TBL] [Abstract][Full Text] [Related]
14. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration.
Pollick C; Kimball B; Henderson M; Wigle ED
Am J Cardiol; 1988 Dec; 62(17):1248-51. PubMed ID: 3195486
[TBL] [Abstract][Full Text] [Related]
15. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
[TBL] [Abstract][Full Text] [Related]
16. Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine.
Strauer BE; Atef Mahmoud M; Bayer F; Bohn I; Motz U
Eur Heart J; 1984 Dec; 5 Suppl F():53-60. PubMed ID: 6241903
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
Kaltenbach M; Hopf R
J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978
[TBL] [Abstract][Full Text] [Related]
18. [Drug therapy of hypertrophic cardiomyopathy].
Hartmann A; Kaltenbach M; Hopf R
Fortschr Med; 1992 Sep; 110(27):485-8. PubMed ID: 1358773
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy.
Spicer RL; Rocchini AP; Crowley DC; Vasiliades J; Rosenthal A
Circulation; 1983 Feb; 67(2):413-20. PubMed ID: 6681534
[TBL] [Abstract][Full Text] [Related]
20. Correction of intraoperative diastolic myocardial dysfunction with nifedipine.
Lee TH; DiSesa VJ; Cohn LH; Lilly LS; Antman EM
Clin Cardiol; 1983 Nov; 6(11):549-52. PubMed ID: 6685592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
